Axia Collagenna Skin Care products group has announced that it has reached an agreement with the Prime Pharma marketing and product development Mahonia that were clinically proven to help relieve the symptoms associated with psoriasis
OTTAWA, Ontario, CANADA| August 11, 2011 | Axia Group (Pink Sheets: AGIJ.pk-News) Collagenna Skin Care products, has announced that it has reached an agreement with the Prime Pharma, a subsidiary of TSE listed company allegiance Equity Corporation (TSXV: ANQ.V) www.allegianceequity.com for marketing and product development that Mahonia were clinically proven to help relieve the symptoms associated with psoriasis.
Premier product is the Prime Pharma Relieva over cream, cream of psoriasis counter that has been rewritten in a more effective. The agreement is based on a joint venture for worldwide sales, not for internet marketing of the product retrieved Mahonia, current and future products.
Agreement will enable access Collagenna company patents worldwide, as well as new technology patentable. With Mahonia as a proven active ingredient, first Pharma owns a patented extract with which the company expects to find innovative ways to help distinguish the company from the competition.
Collagenna plans to start clinical trials to validate the preliminary tests and hopes to publish the results in the next 30 days.
The company has started the necessary regulatory documents that will allow Collagenna to the market in Canada and United States Relieva. The company expects this process to take about 60 days. In the meantime will start marketing efforts immediately.
An independent report (research and markets) of the 2004 market prescription psoriasis world concluded this market to grow at a compound annual rate of 23.6% to more than $ 3.1b worldwide by 2009. According to the Global Industry analysts Inc., global medicines market will surpass psoriasis 7.3 billion by 2015.
Skin care products Collagenna is specialized in anti-aging products with an emphasis on stimulating collagen both locally and internally. The company sells its products primarily through its specialized clinical care of the skin through its ever-expanding network of distribution partners.
More details and updates will be provided little and in a timely manner.
Foods and food ingredients are suddenly in the spotlight. Corn Products International (CPO) has seen sales rebound dramatically from the depths of the recession. Earnings are expected to grow by 25% in 2011. This Zacks # 1 Rank (strong buy) is the largest manufacturer of dextrose in the world and produces starches, corn syrup, high fructose and glucose. The company provides a variety of ingredients for customers in 60 industries including food, beverages, pharmaceuticals, feed, corrugating, paper and textiles in 50 countries around the world. Corn Products places Big Beat in the fourth quarter of 2010 Feb 17, corn products reports fourth quarter results and easily surprised Zacks consensus estimate of 44%. Earnings per share were $ 1.05 compared with the consent of 73 cents. The company has just 74 cents a year ago. National starch acquisition added 23 cents per share in the quarter. Full year EPS also rose to $ 3.24 from $ 2.01, excluding costs of national starch acquisition and integration. Sales in the fourth quarter jumped 47% to $ 1.41 billion from 959 million with $ 416 million from higher volumes, including 351 million dollars of sales from national starch. The company was able to handle the higher input costs due to increased volumes in all regions. North America continues to be the largest market. Sales increased 33% to 742 million on stronger volumes of 203 million, including $ 168 million from national starch. South America sales, the second largest market, rose by 23%. Asia grew 119%. Meanwhile, Europe had only national starch sales, so there was no year-over-year comparison. Orientation 2011 The company is confident in 2011, which will be his first full year with the integrated national starch. Earnings per share are expected in the range of $ 3.60 for $ 3.90, but which also includes the cost of acquisition. ascent of Zacks consensus estimates Analysts have been moving their higher estimates based on results for the fourth quarter and full year Outlook. They have also been excluded expenditure of national starch, which means that the predictions are coming over guidance range of the company. 5 estimates moved higher for 2011 last week that drove the Zacks consensus estimate of up to $ 4.06 2011 from $ 3.65 per diluted share. Value in equities CPO Corn products has attractive valuations. It is trading just 12 x forward estimates that is below the average S & P 500 x 14.5. It also has a price-to-book only 1.9, even within the parameters of value below 3.0. Ratio of price-to-business sales of 0.9 also indicates the value. Also, the 1-year return on equity is a strong 13.2%. CPO 1 year Highs Actions have pulled back from 1 year highs the recent market sell-off. But the chart 6 months is still quite impressive. Tracey Ryniec is the strategist of Stock value for Zacks.com. She is also the Editor in charge of service market-beating Zacks value Trader. You can follow her at twitter.com/traceyryniec. MAIS PROD INTL (CPO): Free Stock Analysis reports Zacks Investment Research
Translate Request has too much data Parameter name: request Translate Request has too much data Parameter name: request Exploring Technology And Pharmaceutical Naming: Branding Strategy Insider Branding Strategy InsiderSearch WWW This Blog
About The AuthorsDerrick Daye Managing Partner Email Derrick Derrick has spent the past 18 years helping organizations release the full potential of their brands. His experience is as deep as it is diverse encompassing the disciplines of advertising, branding, sales promotion and public relations. Most notably he has worked with the White House Press Corps, Johnson & Johnson and the National Basketball Association.
Call The Blake Project - here's my cell: 813.842.2260 Brad VanAuken Chief Brand Strategist Email Brad Recognized as one of the world’s leading experts on brand management and marketing, Brad wrote the best selling book Brand Aid, the first comprehensive practical, ‘how-to’ guide on building winning brands. A much sought after consultant and speaker, he writes extensively for the business press and academic journals and is regularly quoted in trade publications.
AdvertiseReach Decision Makers here on Branding Strategy Insider. Recent PostsExploring Technology And Pharmaceutical Naming10 Warning Signs Your Brand Is FailingBrands And The Feelings They EvokeThe Advertising Wisdom Of Rosser Reeves1 Minute Brand Positioning Self Analysis5 Drivers Of Brand InsistenceBrand Management Of The Future41 Causes Of Brand FailureA Question Of Line ExtensionLicensing The Beverly Hills BrandCategories?Branding Bag?Ad Industry IconsAdvertisingBrad VanAukenBrand AccessibilityBrand AidBrand ArchitectureBrand DefinitionsBrand DifferentiationBrand EducationBrand Equity Brand EssenceBrand ExtensionBrand IdentityBrand ImageryBrand InsistenceBrand LicensingBrand LoyaltyBrand ManagementBrand MarketingBrand PositioningBrand PromiseBrand ProtectionBrand RecallBrand ResearchBrand SponsorshipsBrand SpotlightBrand StrategyBrand Value & PricingBrand WatchBranding & LeadershipBranding & RetailBranding and ColorsBranding and Cultural DifferencesBranding and Social MediaBranding and Social ResponsibilityBranding BasicsBranding IdeasBranding RallyBranding SnapshotBranding TrendsBranding: Just Ask...BrandingWireBrandQuotesBuilding Emotional ConnectionsBuilding Winning BrandsBusiness & Branding: What if?Business to Business (B2B)Business to Consumer (B2C)Change the Voice in Your HeadChief Marketing OfficerCommon Brand ProblemsCorporate BrandingCustomer InsightCustomer Touchpoint ManagementDerrick DayeDid You Know?EndorsementsFuture Of BrandingGlobal BrandingGreat MomentsIdeation and Creative Problem SolvingIndustry IssuesInternal Brand BuildingJack TroutLaws of MarketingLicensingLine ExtensionLuxury BrandingMark RitsonMarket ResearchMarketers For CharityMarketingMarketing and ChinaMarketing To WomenMartin LindstromNamingNeuromarketingOpinionPersonal BrandingPlace BrandingProduct PlacementPublic Relations & BrandingRe-BrandingRecession MarketingSensory BrandingSlogans/Taglines/JinglesSmall Business BrandingSteve RivkinTop 100 BrandsUniversity BrandingWord of MouthArchivesOctober 2010September 2010August 2010July 2010June 2010May 2010April 2010March 2010February 2010January 2010More...Recognition
« 10 Warning Signs Your Brand Is Failing |MainOctober 30, 2010Exploring Technology And Pharmaceutical Naming
In the naming playground, technology and pharmaceutical firms are among the busiest performers. So we asked Mark Steiner, a nationally recognized intellectual property attorney, for his take on the good, the bad and the ugly in those fields. Steiner heads the trademark & copyright practice group at Townsend and Townsend and Crew in San Francisco.
Q: Mark, what’s your general advice to people who want to name companies and products in technology and pharmaceuticals?
When it comes to trade name and trademark selection, it is important that the company make every effort to pick a name and mark which are appealing from a marketing standpoint and protectable from a legal perspective.
As to the latter, we are looking for a mark which is distinctive. This means that the company should be creative and avoid the temptingly easy route of coming up with a mark which is descriptive of the products. The best marks are those which have no meaning whatsoever within the context of the industry: A fanciful, coined term which is a made-up word (think "Exxon" or "Kodak") or an English word which has no relevant meaning, such as "Apple" for computers.
Such marks are most likely to be available when we conduct proper trademark searches and will afford the company broad and strong trademark rights. The mark will most likely be relatively easy to register in the United States and abroad and, if there are no other marks which are similar in appearance, sound and meaning in the industry, the company will be able to enforce its trademark rights against others who would dare come close.
Q: What are some examples of successful names in technology and pharma land?
XIENCE, SurgRx and FlowMedica for medical and surgical devices are strong names and marks. They are distinctive, registrable and enforceable against third parties.
Q: You’ve criticized “cute” names and once described Codegrok as one of the worst names you’d ever encountered. Still feel that way?
Actually, it is good that I am called upon only to look at the legal issues relating to the selection and protection of names and trademarks because I do not consider myself a marketing expert. I leave the "cute" and "catchy" decisions up to the marketing folks. If the proposed name and mark looks to be available and enforceable from a legal standpoint, I am in favor of it.
Q: We see drug names that look as if Scrabble tiles were tossed onto a table – Zixoryn or Zostrix. But other drug names such as Aleve or Allegra or Claritin have clear meanings and associations. Are some drug companies just taking the easy way out?
The names which you characterize as Scrabble tile or random are those which I mentioned earlier as fanciful and strong marks. They are made-up words which, when checked for legal availability, stand an excellent chance of being unique and distinctive.
Then again, the second category of drug names you mentioned are also coined terms which should be strong trademarks. They are actually favored by marketers because, while they are not descriptive of the drugs, they might suggest a characteristic or quality of the drug's benefits. So, they really do not have clear meanings or associations except through advertising, publicity and consumer recognition over time. Both types of marks are strong and favored by trademark counsel.
Q: What about the practice of creating “parent/child” relationships between a company name and its products? One example would be the company Supergen and its drug Dacogen.
The concept of a "family" of names and marks is recognized in trademark law. Using your example, if there are no other "gen" suffix formatives in the relevant industry, the owner of these marks would enjoy broader legal protection for the names the longer they are unique to the industry and as the family of marks grows.
Suppose the company had several "gen" suffix marks which it had used and registered for some time. It would be very difficult to defend a competitor who would now enter the arena with a "gen" suffix mark, even if the term as a whole is different from any single mark in the trademark owner's family.
Q: Anything wrong with straightforward, descriptive names? I’m thinking of names such as MultiPrep and OptiPrep, which are grinding/polishing equipment from Allied High Tech Products Inc.
One could debate whether the examples you cited are what trademark attorneys would consider descriptive or suggestive trademarks. But, as I mentioned earlier, a truly descriptive term is one that companies should take pains to avoid.
Marketers often desire a trademark that describes the product. That desire, when weighed against the legal benefits of marks which are not descriptive, can sometimes create tension between marketing desires and trademark law.
I tell my clients that if they are willing to be more creative from the get-go, they will enjoy tremendous benefits over the life of the product by selecting a mark which does not merely describe the product and its characteristics.
Q: If a technology company finds itself with a name that’s become old-fashioned or no longer appropriate, what should it do?
This is really a marketing question. Nevertheless, I have worked with clients who find themselves in this situation from time to time. Sometimes the existing mark can be updated by changing its appearance in terms of the logo, font or surrounding artwork. This is the best solution from a legal standpoint because then can still enjoy the many years of use of the word portion of the mark. Priority is the name of the game when it comes to competing trademark interests and it is best to bootstrap early use into an updated mark.
The alternative, of course, is to start over and select a new name and start the priority clock running through the prompt filing of trademark applications.
Q: Some companies adopt all-initial names such as TJX, SPX, TXU, AES or CNF. And a personal favorite: “JCP&L, a GPU Company.” Are these really names, or just disguises in the corporate protection program?
Multi-letter, unpronounceable marks are generally protectable, if there are no others already existing in the relevant field. There can be issues overseas, however, in trying to protect such names and marks. At best, however, the scope of protection is rather narrow.
If I can convince a client to come up with a name or mark which will allow for broader legal protection, I will encourage them to do so. Of course, an initial mark which is short for a protectable word mark is not a bad thing, if both are used and registered.
Sponsored By: Brand Aid
Posted by Steve Rivkin in Naming, Steve Rivkin | PermalinkTechnorati Tags:Brand Naming, Branding, FlowMedica, SurgRx, XIENCETrackBack
TrackBack URL for this entry: http://www.typepad.com/services/trackback/6a00d83451b74a69e2013488963257970c
Listed below are links to weblogs that reference Exploring Technology And Pharmaceutical Naming:
Comments Verify your Comment Previewing your CommentPosted by: |
This is only a preview. Your comment has not yet been posted.
Your comment could not be posted. Error type: Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment The letters and numbers you entered did not match the image. Please try again.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Post a comment Comments are moderated, and will not appear until the author has approved them. Comment below or sign in with TypePad Facebook Twitter and more... You are currently signed in as (nobody). Sign Out (URLs automatically linked.)
Your Information
(Name and email address are required. Email address will not be displayed with the comment.)
Name is required to post a comment
Please enter a valid email address
Invalid URL
PartnersPrefer email to a blog?Sign up below and we'll send new posts to your email inbox. We'll never spam, sell or trade your address.
Enter your email address:
Delivered by FeedBurner
BSI on your Phone or BlogOur Feed In A Widget Our Feed On Your Phone Featured Reading
BRAND AID:An Easy Reference Guide to Solving Your Toughest Branding Problems and Strengthening Your Market Position. Order Brad's Best-Seller Here.2010 Brand Education Seminars
The Blake Project offers comprehensive seminars on many key branding topics. They are designed to educate and empower executives, brand managers and marketing professionals to release the full potential of their brands.Download Brand Education Topics.pdf (675.2K)Subscribe to the Brand Management Newsletter A leading source for brand management insight, strategy and advice for marketing oriented leaders and professionals.
Name:
Email:
Marketers Seeking EmploymentFind A Marketer. Feature Your Resume. Change The World.Free DownloadsBrand Aid - Chapter 1Brand Aid - Chapter 2 Follow BSI.bn_widget {margin:20px 5px;padding:0px;padding-top:3px;font-family:'Lucida Grande',Verdana,Arial,Sans-Serif;font-size:11px;font-weight:normal;text-decoration:none;background:#3B5998 none repeat scroll 0% 0%;border:none;}.bn_widget .bn_header {padding:1px;font-size:11px;font-weight:bold;color:#FFFFFF;text-align:center;}.bn_widget .bn_footer {padding:1px;font-size:9px;font-weight:bold;color:#FFFFFF;text-align:center;}.bn_widget .bn_body {background-color:#FFFFFF;color:#444444;padding:4px;border-left:1px solid #D8DFEA;border-right:1px solid #D8DFEA;text-align:center;font-size:1.1em;}.bn_widget a {text-decoration:underline;color:#666666;font-weight:bold;}.bn_widget .bn_footer a {text-decoration:none;color:#FFFFFF;font-weight:bold;}Join our blog network on FacebookBlog NetworksBlog RollAdFreakBob BlyBrand MixBrand Strategy MagazineConverStationsDetective MarketingKevin RobertsMEDIA 2.0Search Engine JournalShimon SandlerSparxooSurvival of the Fastest ChannelThe Brand ElasticTop TenBenefits of Building Strong Brands Increased revenues and market share Decreased price sensitivity Increased customer loyalty Additional leverage with vendors and retailers (for manufacturers) Increased profitability Increased stock price, shareholder value and sale value Increased clarity of vision Increased ability to mobilize an organization's people and focus its activities Increased ability to expand into new product and service categories Increased ability to attract and retain high quality employees document.write(unescape("%3Cscript src='" + (document.location.protocol == "https:" ? "https://sb" : "http://b") + ".scorecardresearch.com/beacon.js'%3E%3C/script%3E"));COMSCORE.beacon({ c1: 2, c2: "6035669", c3: "", c4: "http://www.brandingstrategyinsider.com/2010/10/technology-and-pharma-brand-naming.html", c5: "", c6: "", c15: ""});
September 28, 2010 (China and knowledge) imports and exports of electromechanical products in China increased by almost 40% in the first half of this year, while exports of electromechanical products high-tech has seen gaining weight, Xinhua News Agency reported.
In the first six months, imports and exports of electromechanical products totaled $ 719 Chinese. 6 billion, 39.8% year on year, or accounting for 53.1% of total trade, said Ji Zhang, an official of the Chinese Ministry of Commerce.
Exports of electromechanical products amounted to 416.97 billion, increased by 35.9% in the similar period last year, or accounting 59.1% of total exports, while Imports increased 17.9% year on year to 302.64 billion, equal to 46.6% of total imports.
During the period of January to June, exports of high technology products, equal to 210.19 billion, accounting for 50.4% of total exports electromechanical products, 16.2% year on year over the same period last year.
At the same time, imports of electromechanical products swelled 45.9% year on year to 183.78 billion, or accounting for 60.7% of the total.
Tracey Ryniec is the strategist of Stock value for Zacks.com. She is also the Editor in charge of service market-beating Zacks value Trader. You can follow her at twitter.com/traceyryniec.
Article index
About The Authors
Derrick Daye
Brad VanAuken
« 10 Warning Signs Your Brand Is Failing |MainOctober 30, 2010Exploring Technology And Pharmaceutical Naming
Your comment could not be posted. Error type: Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment The letters and numbers you entered did not match the image. Please try again. 
Our Feed On Your Phone
Featured Reading
.bn_widget {margin:20px 5px;padding:0px;padding-top:3px;font-family:'Lucida Grande',Verdana,Arial,Sans-Serif;font-size:11px;font-weight:normal;text-decoration:none;background:#3B5998 none repeat scroll 0% 0%;border:none;}.bn_widget .bn_header {padding:1px;font-size:11px;font-weight:bold;color:#FFFFFF;text-align:center;}.bn_widget .bn_footer {padding:1px;font-size:9px;font-weight:bold;color:#FFFFFF;text-align:center;}.bn_widget .bn_body {background-color:#FFFFFF;color:#444444;padding:4px;border-left:1px solid #D8DFEA;border-right:1px solid #D8DFEA;text-align:center;font-size:1.1em;}.bn_widget a {text-decoration:underline;color:#666666;font-weight:bold;}.bn_widget .bn_footer a {text-decoration:none;color:#FFFFFF;font-weight:bold;}Join our blog network